Upper-limb Active Function and Botulinum Toxin a

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
StrokeMuscle SpasticityUpper Extremity Paralysis
Interventions
OTHER

Clinical evaluation

For the control group : only one clinical evaluation : search for non-inclusion criteria and manual laterality score

OTHER

Clinical evaluation and Instrumental evaluation

For the patient : The standard clinical examination to evaluate movement : pain, motive power, spasticity plus Edinburgh's laterality score and Sensitivity deficiency by the Erasmus Nottingham Sensory Assessment (EmNSA) score and the evaluation of the cognitive function An encephalic MRI An instrumental evaluation : with concomitant recording of 3D kinematic data, surface and intramuscular EMG of the flexor and elbow extensor muscles, and EEG during active elbow extension, paretic and non-paretic movements.

Trial Locations (1)

31059

RECRUITING

University Hospital Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER